Ocuphire Pharma Inc Target price 2024 - Analyst rating & recommendation
Powered by
Ocuphire Pharma Inc Classifications & Recommendation:
Buy
100%
Ocuphire Pharma Inc Target price
| Target price | $19.33 |
| Course | $1.52 |
| Price potential |
1,171.93%
register free of charge
|
| Number of estimates | 3 |
|
3 Analysts have issued a price target Ocuphire Pharma Inc 2025 .
The average Ocuphire Pharma Inc target price is $19.33.
This is
1,171.93%
register free of charge
$20.00
1,215.79%
register free of charge
$18.00
1,084.21%
register free of charge
|
|
| A rating was issued by 3 analysts: 3 Analysts recommend Ocuphire Pharma Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Ocuphire Pharma Inc share has an average upside potential 2025 of
1,171.93%
register free of charge
|
Sales and margin forecast 2024, 2025 to 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Turnover Million $ | 19.05 | 16.35 |
| 52.20% | 14.17% | |
| Net margin | -60.58% | -47.57% |
| 210.60% | 21.48% |
3 Analysts have issued a sales forecast Ocuphire Pharma Inc 2024 . The average Ocuphire Pharma Inc sales estimate is
$16.4m
unlock
13.99%
lower
unlock
$33.8m
77.54%
unlock
$7.3m
61.60%
unlock
This results in the following potential growth figures:
Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Earnings per share $ | -0.46 | -0.31 |
| 152.87% | 32.61% | |
| P/E ratio | negative | |
| EV/Sales | negative |
Based on analysts' sales estimates for 2024, the Ocuphire Pharma Inc share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
-0.48
unlock
2.41
unlock
This results in the following potential growth figures and future valuations:
Ocuphire Pharma Inc...
Discover more stocks with a high price target
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
